If You Invested $30,000 in CRISPR Therapeutics in 2016, This Is How Much You Would Have Today
The Motley Fool
SEPTEMBER 16, 2023
But just how well has the stock done over the years, and would it have proven to be a good investment if you bought shares at its initial public offering? A 240% return in less than a decade Oct. 19, 2016 was officially CRISPR Therapeutics' first day of trading. Should you buy CRISPR Therapeutics stock today?
Let's personalize your content